Compare PANL & MRVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PANL | MRVI |
|---|---|---|
| Founded | 1996 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Marine Transportation | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 476.2M | 472.8M |
| IPO Year | 2015 | 2020 |
| Metric | PANL | MRVI |
|---|---|---|
| Price | $7.17 | $3.55 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 4 |
| Target Price | ★ $9.00 | $4.13 |
| AVG Volume (30 Days) | 437.7K | ★ 2.0M |
| Earning Date | 05-11-2026 | 05-07-2026 |
| Dividend Yield | ★ 2.76% | N/A |
| EPS Growth | N/A | ★ 14.29 |
| EPS | ★ 0.30 | N/A |
| Revenue | ★ $385,088,209.00 | $185,743,000.00 |
| Revenue This Year | $0.72 | $12.54 |
| Revenue Next Year | N/A | $7.87 |
| P/E Ratio | $24.15 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $3.94 | $1.96 |
| 52 Week High | $9.39 | $4.11 |
| Indicator | PANL | MRVI |
|---|---|---|
| Relative Strength Index (RSI) | 42.83 | 59.98 |
| Support Level | $6.59 | $3.25 |
| Resistance Level | $7.35 | $3.65 |
| Average True Range (ATR) | 0.23 | 0.20 |
| MACD | 0.00 | 0.06 |
| Stochastic Oscillator | 11.31 | 75.25 |
Pangaea Logistics Solutions Ltd and its subsidiaries collectively, Pangaea or the Company, provide seaborne drybulk logistics and transportation services as well as terminal and stevedoring services. Pangaea utilizes its logistics expertise to service a broad base of industrial customers who require the transportation of a wide variety of dry bulk cargoes, including grains, coal, iron ore, pig iron, hot briquetted iron, bauxite, alumina, cement clinker, dolomite, and limestone. The Company's operating segments include the shipping segment: The Company's operating segments include the shipping segment and six terminal and stevedoring operating segments. The company operates in the USA, Germany, Canada, Singapore, the United Kingdom, and other countries, with maximum from the USA and others.
Maravai LifeSciences Holdings Inc is a life sciences company that provides critical products that drive the development of groundbreaking vaccines, drug therapies, cell and gene therapies, and diagnostics. The group's solutions empower research into human diseases and support the entire biopharmaceutical development process from early discovery to commercialization. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.